Clinical trials: Phase III trial results for tofacitinib bring new oral DMARD therapy a step closer for patients with rheumatoid arthritis
Nat Rev Rheumatol
.
2012 Oct;8(10):561.
doi: 10.1038/nrrheum.2012.145.
Epub 2012 Aug 28.
Author
Emma Leah
PMID:
22926344
DOI:
10.1038/nrrheum.2012.145
No abstract available
Publication types
Comment